Pancreatic Cancer Research

ResearcherUniversity of HelsinkiActive in the last 2 years

Panu Aaltonen

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2385-0601; OpenAlex author ID A5019557698. Sources: OpenAlex.

Their work

Papers
3 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 3

  1. Diabetes Among Finnish Pancreatic Cancer Patients: Prevalence, Time Interval Between Diabetes and Cancer Diagnosis, and Overall Survival. First author DOI 10.1002/cam4.72380↗
  2. Venous thromboembolism incidence and association with overall survival in pancreatic cancer: A Finnish nationwide cohort study. Co-author DOI 10.1002/cam4.70014↗
  3. Long-term nationwide trends in the treatment of and outcomes among pancreatic cancer patients. Co-author DOI 10.1016/j.ejso.2021.11.116↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hanna E. Seppänen · 2 shared papers, 2022–2024 · strength 0.40
  2. Olli Carpén · 2 shared papers, 2022–2024 · strength 0.40
  3. Caj H. Haglund · 2 shared papers, 2022–2024 · strength 0.40
  4. Pauli Antero Puolakkainen · 2 shared papers, 2022–2024 · strength 0.40
  5. Seppänen Hanna · 1 shared paper, 2026 · strength 0.39
  6. Suitiala Roosa · 1 shared paper, 2026 · strength 0.39
  7. Malin Sund · 1 shared paper, 2026 · strength 0.39
  8. Riitta Lassila · 1 shared paper, 2024 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.